
Quarterly report 2025-Q3
added 11-10-2025
Health Catalyst Net Debt 2011-2026 | HCAT
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt Health Catalyst
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -94.9 M | 125 M | 114 M | -8.86 M | 79.7 M | 240 M | -1.52 M | -10.4 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 240 M | -94.9 M | 55.4 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Health information services industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cerner Corporation
CERN
|
720 M | - | - | $ 27.9 B | ||
|
Change Healthcare
CHNG
|
4.65 B | - | - | $ 9.03 B | ||
|
Computer Programs and Systems
CPSI
|
193 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
863 M | - | - | $ 2.94 B | ||
|
Accolade
ACCD
|
-12 M | - | 0.29 % | $ 206 M | ||
|
Castlight Health, Inc.
CSLT
|
-34.4 M | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
67.9 M | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
763 M | - | - | $ 6.37 B | ||
|
Evolent Health
EVH
|
232 M | $ 4.18 | 0.84 % | $ 392 M | ||
|
HealthStream
HSTM
|
-39.3 M | $ 22.42 | -1.45 % | $ 681 M | ||
|
iCAD
ICAD
|
-16.8 M | - | - | $ 102 M | ||
|
Akerna Corp.
KERN
|
13.7 M | - | - | $ 161 M | ||
|
HealthEquity
HQY
|
480 M | $ 98.07 | 0.31 % | $ 8.39 B | ||
|
American Well Corporation
AMWL
|
-220 M | $ 5.23 | 0.77 % | $ 78.4 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
181 M | - | -10.39 % | $ 886 M | ||
|
MTBC
MTBC
|
-3.52 M | - | -0.58 % | $ 51.7 M | ||
|
So-Young International
SY
|
-563 M | $ 2.61 | 1.76 % | $ 207 M | ||
|
GoodRx Holdings
GDRX
|
44 M | $ 2.78 | -2.63 % | $ 1.07 B | ||
|
OptimizeRx Corporation
OPRX
|
20.6 M | $ 13.25 | -4.33 % | $ 227 M | ||
|
Omnicell
OMCL
|
-327 M | $ 50.47 | 6.35 % | $ 2.32 B | ||
|
1Life Healthcare
ONEM
|
-41.2 M | - | - | $ 3.37 B | ||
|
Progyny
PGNY
|
-143 M | $ 27.54 | 2.76 % | $ 2.36 B | ||
|
Phreesia
PHR
|
-84 M | $ 16.91 | -3.54 % | $ 923 M | ||
|
Premier
PINC
|
128 M | $ 28.26 | - | $ 2.33 B | ||
|
R1 RCM
RCM
|
638 M | - | - | $ 3.81 B | ||
|
NantHealth
NH
|
4.4 M | - | -46.64 % | $ 10.4 M | ||
|
Schrödinger
SDGR
|
-29.5 M | $ 18.67 | -0.52 % | $ 1.36 B | ||
|
NextGen Healthcare
NXGN
|
-42.1 M | - | - | $ 1.6 B | ||
|
Signify Health
SGFY
|
-126 M | - | -0.02 % | $ 7.21 B | ||
|
10x Genomics
TXG
|
-264 M | $ 19.32 | -3.35 % | $ 2.26 B | ||
|
Streamline Health Solutions
STRM
|
2.4 M | - | - | $ 21.4 M | ||
|
Teladoc Health
TDOC
|
-297 M | $ 7.57 | - | $ 1.29 B | ||
|
Veeva Systems
VEEV
|
-648 M | $ 242.72 | 1.46 % | $ 39 B | ||
|
Tabula Rasa HealthCare
TRHC
|
-54.5 M | - | - | $ 255 M | ||
|
SCWorx Corp.
WORX
|
-376 K | $ 0.2 | -1.51 % | $ 292 K |